A randomized controlled trial evaluates if selective early treatment of patent ductus arteriosus reduces death or bronchopulmonary dysplasia at 36 weeks in extreme preterm babies. Findings from the ...

This section presents medications that are known to potentially lead to 'Patent ductus arteriosus' as a side effect. It's important to note that mild side effects are quite common with medications.

Early screening echocardiography for patent ductus arteriosus in preterm infants was associated with lower rates of in-hospital mortality and pulmonary hemorrhage compared with no screening, ...

Pharmacological and/or surgical closure of a hemodynamically significant patent ductus arteriosus (PDA) in the very preterm infant has been the standard of care over the past few decades. However, the ...

ANGIOCARDIOGRAPHY—contrast visualization of the heart and great vessels — was first made a practical procedure by Robb and Steinberg 1 in 1938. In subsequent reports these authors have described in ...

Patent ductus arteriosus (PDA) is a congenital cardiac defect that occurs when the ductus arteriosus fails to close. The result is a persistent communication between the aorta and pulmonary artery, ...

Patent Ductus arteriosus is the second commonest congenital birth defect of the heart and can cause heart failure; however majority of these defect close spontaneously after birth. Patent Ductus ...

Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...

This article presents common misconceptions about the physiologic significance of early ductal shunting and reviews the evidence regarding the preferential use of echocardiography rather than reliance ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

Char syndrome is a rare genetic condition that affects how a baby’s face, heart, and hands develop. It’s been found in only a few families worldwide. People with the condition have distinctive facial ...